Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2438 participants
OBSERVATIONAL
2008-11-30
2012-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Ventricular Arrhythmia Risk After CRT-D Replacement for Patients With Primary Prevention Indication
NCT02323503
Myocardial Work and Metabolism in CRT
NCT02537782
Metabolic Mapping and Cardiac Resynchronization
NCT03420833
ConsultaTM CRT-D Clinical Evaluation Study
NCT00526162
Cardiac Resynchronization Therapy (CRT)-Narrow-dp/Dt-Study
NCT00821938
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The primary objective of this Survey is to describe current European practice based on a broad sampling in 13 countries. The information collected will enable practice between centres and countries to be compared and permit benchmarking with national and international practice. The survey provides valuable quality assurance assessment for individual centres, permits limited economic analyses and broadly evaluates adherence to guideline recommendations.
The following 13 European countries contributed patients to the survey: Austria, Belgium, France, Germany, Ireland, Israel, Italy, the Netherlands, Norway, Spain, Sweden, Switzerland and UK. Two national coordinators, one each from the fields of heart failure and electrophysiology, were selected and given the responsibility to facilitate recruitment in their respective countries.
Follow the link for complete list of the members of the Scientific Committee and national coordinators.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Boston Scientific Corporation
INDUSTRY
Medtronic
INDUSTRY
Abbott Medical Devices
INDUSTRY
Biotronik SE & Co. KG
INDUSTRY
LivaNova
INDUSTRY
Roche Diagnostic Ltd.
INDUSTRY
Helse Stavanger HF
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kenneth Dickstein, MD, PHD
Role: STUDY_CHAIR
HFA of the ESC
Silvia Priori, MD, PHD
Role: STUDY_CHAIR
EHRA of the ESC
Angelo Auricchio, MD, PHD
Role: STUDY_DIRECTOR
EHRA of the ESC
Josep Brugada, MD, PHD
Role: STUDY_DIRECTOR
EHRA of the ESC
John Cleland, MD, PHD
Role: STUDY_DIRECTOR
HFA of the ESC
Geneviève Derumeaux, MD, PHD
Role: STUDY_DIRECTOR
EAE of the ESC
Daniel Gras, MD, PHD
Role: STUDY_DIRECTOR
EHRA of the ESC
Michel Komajda, MD, PHD
Role: STUDY_DIRECTOR
HFA of the ESC
Cecilia Linde, MD, PHD
Role: STUDY_DIRECTOR
EHRA of the ESC
John Morgan, MD, PHD
Role: STUDY_DIRECTOR
EHRA of the ESC
Dirk J van Veldhuisen, MD, PHD
Role: STUDY_DIRECTOR
HFA of the ESC
Anselm Gitt, MD
Role: STUDY_DIRECTOR
The Institut für Herzinfarktforschung in Ludwigshafen, Germany
Nigussie Bogale, MD
Role: STUDY_DIRECTOR
Stavanger University Hospital and University of Bergen, Norway
References
Explore related publications, articles, or registry entries linked to this study.
CRT Survey Scientific Committee. European cardiac resynchronization therapy survey: rationale and design. Eur J Heart Fail. 2009 Mar;11(3):326-30. doi: 10.1093/eurjhf/hfp030.
Dickstein K, Bogale N, Priori S, Auricchio A, Cleland JG, Gitt A, Limbourg T, Linde C, van Veldhuisen DJ, Brugada J; Scientific Committee; National Coordinators. The European cardiac resynchronization therapy survey. Eur Heart J. 2009 Oct;30(20):2450-60. doi: 10.1093/eurheartj/ehp359. Epub 2009 Aug 31.
Bogale N, Priori S, Cleland JG, Brugada J, Linde C, Auricchio A, van Veldhuisen DJ, Limbourg T, Gitt A, Gras D, Stellbrink C, Gasparini M, Metra M, Derumeaux G, Gadler F, Buga L, Dickstein K; Scientific Committee, National Coordinators, and Investigators. The European CRT Survey: 1 year (9-15 months) follow-up results. Eur J Heart Fail. 2012 Jan;14(1):61-73. doi: 10.1093/eurjhf/hfr158.
Bogale N, Witte K, Priori S, Cleland J, Auricchio A, Gadler F, Gitt A, Limbourg T, Linde C, Dickstein K; Scientific Committee, National coordinators and the investigators. The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades. Eur J Heart Fail. 2011 Sep;13(9):974-83. doi: 10.1093/eurjhf/hfr085. Epub 2011 Jul 19.
Related Links
Access external resources that provide additional context or updates about the study.
Synopsis of the Survey, list of participating countries and members of the Scientific Committee and national coordinators
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CRT Survey
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.